Przejdź do zawartości
Merck
  • Association of cholesterol uptake capacity, a novel indicator for HDL functionality, and coronary plaque properties: An optical coherence tomography-based observational study.

Association of cholesterol uptake capacity, a novel indicator for HDL functionality, and coronary plaque properties: An optical coherence tomography-based observational study.

Clinica chimica acta; international journal of clinical chemistry (2020-01-24)
Toshihiko Oshita, Ryuji Toh, Yuichiro Nagano, Koji Kuroda, Yoshinori Nagasawa, Amane Harada, Katsuhiro Murakami, Maria Kiriyama, Keiko Yoshikawa, Keiko Miwa, Takuya Kubo, Takuya Iino, Manabu Nagao, Yasuhiro Irino, Tetsuya Hara, Masakazu Shinohara, Hiromasa Otake, Toshiro Shinke, Katsuyuki Nakajima, Tatsuro Ishida, Ken-Ichi Hirata
ABSTRAKT

Cholesterol efflux from atherosclerotic lesion is a key function of high-density lipoprotein (HDL). Recently, we established a simple, high-throughput, cell-free assay to evaluate the capacity of HDL to accept additional cholesterol, which is herein referred to as "cholesterol uptake capacity (CUC)". To clarify the cross-sectional relationship between CUC and coronary plaque properties. We enrolled 135 patients to measure CUC and assess the morphological features of angiographic stenosis by optical coherence tomography (OCT). We estimated the extent of the lipid-rich plaque by multiplying the mean lipid arc by lipid length (lipid index). The extent of the OCT-detected macrophage accumulation in the target plaque was semi-quantitatively estimated using a grading system. Lipid-rich plaque lesions were identified in 125 patients (92.6%). CUC was inversely associated with the lipid index (R = -0.348, P < 0.0001). In addition, CUC was also inversely associated with macrophage score (R = -0.327, P < 0.0001). Conversely, neither circulating levels of HDL cholesterol nor apoA1 showed a similar relationship. We demonstrated that CUC was inversely related to lipid-rich plaque burden and the extent of macrophage accumulation, suggesting that CUC could be useful for cardiovascular risk stratification.

MATERIAŁY
Numer produktu
Marka
Opis produktu

Avanti
TopFluor Cholesterol, Avanti Research - A Croda Brand
Sigma-Aldrich
Sandoz 58-035, >98% (HPLC), powder